The store will not work correctly when cookies are disabled.
(R,E)-(3-hydroxypropylidene)malic Acid
ID: ALA225714
PubChem CID: 24860313
Max Phase: Preclinical
Molecular Formula: C7H10O6
Molecular Weight: 190.15
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)/C(=C/CCO)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C7H10O6/c8-3-1-2-4(6(10)11)5(9)7(12)13/h2,5,8-9H,1,3H2,(H,10,11)(H,12,13)/b4-2+/t5-/m1/s1
Standard InChI Key: JAWMCXNTMFJPQS-XWCPEMDWSA-N
Molfile:
RDKit 2D
13 12 0 0 1 0 0 0 0 0999 V2000
14.1831 -4.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8976 -3.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6153 -4.3410 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9009 -3.1035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1835 -5.1707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4693 -5.5836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8982 -5.5828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9011 -6.4097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6149 -5.1719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4685 -3.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7542 -4.3420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0396 -3.9297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3252 -4.3424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 7 1 6
2 4 2 0
7 8 1 0
7 9 2 0
1 5 1 0
1 10 2 0
1 2 1 0
10 11 1 0
5 6 1 0
11 12 1 0
2 3 1 0
12 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 190.15 | Molecular Weight (Monoisotopic): 190.0477 | AlogP: -1.17 | #Rotatable Bonds: 5 |
Polar Surface Area: 115.06 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.22 | CX Basic pKa: ┄ | CX LogP: -1.27 | CX LogD: -7.89 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.41 | Np Likeness Score: 2.17 |
References
1. Yamamoto T, Miyazaki K, Eguchi T.. (2007) Substrate specificity analysis and inhibitor design of homoisocitrate dehydrogenase., 15 (3): [PMID:17116397] [10.1016/j.bmc.2006.11.008] |